Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ondrej Bilek"'
Autor:
Magda Barinova, Bohuslav Melichar, Karolina Hurdalkova, Martin Svaton, Jiri Blazek, Lenka Jakubíková, M. Černovská, Michal Jirousek, Daniel Krejci, Jana Skrickova, Milada Zemanova, J. Krejčí, Petra Zemanova, Michal Hrnčiarik, Ondrej Bilek, Ondrej Fischer, Juraj Kultan
Publikováno v:
Anticancer Research. 40:2209-2217
To investigate potential association between administration of corticosteroids, antibiotics, probiotics, proton pump inhibitors, non-steroidal anti-inflammatory drugs (NSAID), statins and metformin and outcome in patients with non-small cell lung can
Autor:
Jan Jurica, Jiri Vasina, Lenka Zdrazilova-Dubska, Tomas Kazda, Iveta Selingerová, Alexandr Poprach, Simona Borilova, Ondrej Bilek, Miloš Holánek, Sona Stepankova, Igor Kiss
Publikováno v:
International immunopharmacology. 99
ALK targeting with tyrosine kinase inhibitors (TKIs) is a highly potent treatment option for the therapy of ALK positive non-small cell lung cancer (NSCLC). However, pharmacokinetics of TKIs leads to clinically significant drug interactions, and the
Autor:
Renata Horová, Rostislav Vyzula, Ondrej Slama, Regina Demlová, Ondrej Bilek, Lucie Svetlakova, Jiri Sedo, Lukáš Pochop
Publikováno v:
Journal of Clinical Oncology. 35:113-113
113 Background: Clinical trials in the U.S. and Canada have shown the benefit for patients and the health care system of early integration of palliative care into oncological practice. Nevertheless the practical realisation and the timing of this int